110 results
Page 2 of 6
8-K
EX-99.1
4dmblh
8 Aug 23
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
4:03pm
8-K
EX-1.1
6ilb12mvr3bej 0d
14 Jul 23
Caribou Biosciences Announces Proposed Public Offering of Common Stock
6:33pm
8-K
EX-99.2
xozvyvu2
14 Jul 23
Caribou Biosciences Announces Proposed Public Offering of Common Stock
6:33pm
8-K
EX-99.1
7rnhdt
14 Jul 23
Caribou Biosciences Announces Proposed Public Offering of Common Stock
6:33pm
424B5
enxhlg5qbpp1je
14 Jul 23
Prospectus supplement for primary offering
5:31pm
8-K/A
EX-99.1
p28gk36g52
14 Jul 23
Other Events
4:22pm
424B5
qpqc704vk8d6o4 kwq
13 Jul 23
Prospectus supplement for primary offering
4:56pm
8-K
EX-99.1
k93q cooa4so1
13 Jul 23
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
4:23pm
8-K
EX-99.2
plxp r8e6ljy
13 Jul 23
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
4:23pm
8-K
EX-99.1
4xxwjuqi w1fqfhw
13 Jul 23
Other Events
4:17pm
8-K
7u13rms891veya
6 Jul 23
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
8:01am
8-K
EX-10.1
5tnkmzrgly9qw1i
6 Jul 23
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
8:01am
8-K
EX-99.1
v3jk3t0gs6
6 Jul 23
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
8:01am
8-K
EX-99.1
en0qa7
9 May 23
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
4:05pm
ARS
8c1f843gsvinhqxh3hi
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-99.1
j0m0h
4 Apr 23
Regulation FD Disclosure
8:00am
8-K
EX-99.2
0c6oxt91hi1oqc fg9
12 Dec 22
Caribou Biosciences Reports CB-010 ANTLER Phase 1 Trial Progress
8:00am
8-K
EX-99.1
m3e2 amtb
12 Dec 22
Caribou Biosciences Reports CB-010 ANTLER Phase 1 Trial Progress
8:00am
8-K
EX-99.1
lnbp2 g8r
29 Nov 22
Regulation FD Disclosure
9:00am